Leonard Green & Partners, L.P. Bria Cell Therapeutics Corp. Transaction History

Leonard Green & Partners, L.P.

  • $4.62 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.28 - $11.9 $2.14 Million - $5.95 Million
-500,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$5.91 - $10.14 $2.96 Million - $5.07 Million
500,000 New
500,000 $5.07 Million

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $8.69M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Leonard Green & Partners, L.P. Portfolio

Follow Leonard Green & Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leonard Green & Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Leonard Green & Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email